Vimarsana
Biggest News Aggregation in the World

Semin Nephrol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Semin Nephrol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Semin Nephrol Today - Breaking & Trending Today

New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with - Vimarsana News

New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with

FIGARO-BM, an exploratory human biomarker study, provides additional insight on finerenone's mechanism of action in blocking mineralocorticoid receptor (MR) overactivation1New data presented at the American Society of Nephrology’s (ASN) Kidney Week 2023WHIPPANY, N.J.--(BUSINESS WIRE)--At the American Society of Neph...

New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes - Vimarsana News

New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

WHIPPANY, N.J.--(BUSINESS WIRE)--Nov 2, 2023--

"Diet and Polycystic Kidney Disease: Nutrients, Foods, Dietary Patterns" by Kelly Lambert, Robert Gardos et al. - Vimarsana News

"Diet and Polycystic Kidney Disease: Nutrients, Foods, Dietary Patterns" by Kelly Lambert, Robert Gardos et al.

Polycystic kidney disease (PKD) is a chronic, progressive hereditary condition characterized by abnormal development and growth of cysts in the kidneys and other organs. There is increasing interest in exploring whether dietary modifications may prevent or slow the disease course in people with PKD. Although vasopressin-receptor agonists have emerged as a novel drug treatment in advancing care for people with PKD, several recent landmark trials and clinical discoveries also have provided new insights into potential dietary-related therapeutic strategies. In this review, we summarize the curren...

Source: uow.edu.au
Bayer's Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology | Business - Vimarsana News

Bayer's Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology | Business

WHIPPANY, N.J.--(BUSINESS WIRE)--Aug 31, 2023--

Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial - Vimarsana News

Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial

In adult kidney transplant recipients, correction of metabolic acidosis by treatment with sodium bicarbonate over 2 years did not affect the decline in estimated GFR. Thus, treatment with sodium bicarbonate should not be generally recommended to preserve estimated GFR (a surrogate marker for graft function) in kidney transplant recipients with chronic kidney disease who have metabolic acidosis.